In the agreement, Marcor, an Azelis Americas company, will distribute the SPI Pharma product lines in the United States, and Azelis Canada Pharma Division will be responsible for the Canadian marketplace
MitraClip implants give a new lease of life for frail and elderly patients who cannot go in for conventional open-heart surgery
_256_384.jpg)
The company expects to generate an EBITDA margin before special items of around 27 percent in 2021.
ranules now has a total of 38 ANDA approvals from US FDA.
Paves way for CNS cancer test rollout
The clearance marks a pivotal step forward for the company as it pushes deeper into AI-driven diagnostics and expands its clinical footprint in point-of-care imaging
The company highlighted a series of strategic moves during the year, including the acquisition of WOKADINE, marking its entry into the Rs. 648 Cr Povidone Iodine market
Women’s wellness initiative promoted preventive healthcare, fitness, and self-care awareness across the Mira Bhayandar community
The CDMO segment saw a 22% decline in Q4 due to a strong base in the prior year
Bengaluru startup targets 100+ enterprise clients and global expansion as it aims to transform pharmaceutical sales, marketing, tenders, and distribution using AI agents
Subscribe To Our Newsletter & Stay Updated
